NNNN
Anbio Biotechnology
6.10$
-3.3%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Balance Sheet
Anbio Biotechnology (NNNN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 30 million $. Tick rows to compare them in a chart.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q2 23 | Q4 23 | Q2 24 | Q4 24 | Q2 25 | Q3 25 | Q4 25 | Q1 26 |
|---|---|---|---|---|---|---|---|---|---|
| 14 | 15 | 16 | 19 | 19 | 32 | 30 | 30 | 30 | |
| 14 | 15 | 16 | 19 | 19 | 32 | 30 | 30 | 30 | |
| 7.1 | 11 | 9.7 | 10 | 12 | 6.3 | 7.8 | 7.8 | 7.8 | |
| 8.7 | 11 | 9.7 | 10 | 12 | 16 | 12 | – | 12 | |
| 0.0 | 0.0 | 1.9 | 4.6 | 1.1 | 4.4 | 3.7 | 3.7 | 3.7 | |
| 0.4 | 0.0 | 0.0 | – | – | – | – | – | – | |
| 1.4 | 1.3 | 1.0 | 0.5 | 1.7 | 0.2 | 0.1 | 0.1 | 0.1 | |
| 1.4 | 1.3 | 1.0 | 0.5 | 1.7 | 0.2 | 0.1 | 0.1 | 0.1 | |
| 1.4 | 1.3 | 0.8 | 0.5 | 1.6 | 0.1 | – | 0.0 | – | |
| 13 | 14 | 15 | 18 | 17 | 32 | 30 | 30 | 30 | |
| 13 | 14 | 15 | 18 | 17 | 25 | 24 | 24 | 24 | |
| – | 42 | 42 | 42 | 42 | 44 | 44 | 44 | 44 |
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.